605009 Hangzhou Haoyue Personal Care
- 43.36
- -0.19-0.44%
Hangzhou Haoyue Personal Care News
A-share changes | Haoyue Nursing fell more than 6% in the afternoon, shareholders plan to reduce their holdings at a high level
Glonghui, May 22 | Haoyue Nursing (605009.SH) increased its decline to more than 6% in the afternoon. It is now reported at 44 yuan, with a total market value of 6.83 billion yuan. The stock recently continued to rise to a new high, and recently began to decline. The company announced yesterday after the market that Hangzhou hopes Zhongchuang Industrial Investment Partnership will reduce its holdings by no more than 1.5 million shares, or no more than 0.97% of the company's total share capital. The previously announced 2023 performance growth rate declined markedly compared to before listing in 2020.
Express News | Haoyue Nursing: Controlling shareholders agree to reduce their holdings by no more than 0.97%
Express News | Haoyue Nursing: Hangzhou hopes Zhongchuang Industrial Investment Partnership will reduce its holdings by no more than 1.5 million shares
Haoyue Nursing (605009.SH): The number of shareholders as of April 30 is 16,818
Gelonghui, May 8 | Haoyue Nursing (605009.SH) said on the investor interactive platform that the number of shareholders as of April 30 was 16,818.
Haoyue Nursing (605009): Improving profitability and rewarding shareholders with high dividends
Incident: City Media released its 2023 annual report and 2024 quarterly report. The company's total revenue in 2023 was 2.69 billion yuan, up 5.4%; net profit to mother was 410 million yuan, up 21.4%; no return was deducted
Haoyue Nursing (605009.SH) reported first-quarter results, net profit of 857.484 million yuan, an increase of 7.99% over the previous year
Haoyue Nursing (605009.SH) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Haoyue Nursing (605009): Independent brands continue to promote overseas markets and can be expected to grow
Event: Haoyue Nursing released its 2023 annual report. In 2023, the company achieved operating income of 2,757 billion yuan, a year-on-year decrease of 1.62%; net profit to mother was 439 million yuan, an increase of 3.72%; net profit after deducting net income
SDIC Securities released a research report on April 25 stating that it gave Haoyue Nursing (605009.SH) a purchase rating, and the target price was 58.20 yuan. The main reasons for the rating include: 1) sales of baby hygiene products are increasing steadi
SDIC Securities released a research report on April 25 stating that it gave Haoyue Nursing (605009.SH) a purchase rating, and the target price was 58.20 yuan. The main reasons for the rating include: 1) sales of baby hygiene products are increasing steadily, and product prices affect revenue in the short term as raw material prices drop; 2) strengthening private brand building, and domestic and foreign production capacity is expected to gradually be released. (Mainichi Keizai Shimbun)
Haoyue Care (605009.SH): No products are directly used in the low-altitude economy
Gelonghui, April 18 | Haoyue Care (605009.SH) said on the investor interactive platform that the company's products are disposable consumer goods and are not limited to usage scenarios. We have noticed the recent boom in the low-altitude economy, but the depth and breadth of the dividends brought by the low-altitude sector remains to be seen. Currently, the company has no products directly applied to the low-altitude economy, and whether they are applied indirectly still needs to be observed. At the same time, as a responsible listed company, we are unwilling to forcibly link up with the low-altitude economy to create hot spots.
The Consensus EPS Estimates For Hangzhou Haoyue Personal Care Co., Ltd (SHSE:605009) Just Fell Dramatically
Today is shaping up negative for Hangzhou Haoyue Personal Care Co., Ltd (SHSE:605009) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and
Haoyue Nursing (605009): Release of production capacity, steady development of domestic and foreign markets, and continuous promotion of independent brand building
Incident: The company released its annual report and achieved revenue of 2,757 million yuan in 2023, -1.6% year on year; net profit to mother was 439 million yuan, +3.7% year over year; net profit after deducting non-return to mother was 423 million yuan, +7.4% year on year
Tianfeng Securities released a research report on April 14 stating that it gave Haoyue Nursing (605009.SH) a purchase rating. The main reasons for the rating include: 1) the company released its 2023 report; 2) large Thai and cross-border customers are gr
Tianfeng Securities released a research report on April 14 stating that it gave Haoyue Nursing (605009.SH) a purchase rating. The main reasons for the rating include: 1) the company released its 2023 report; 2) large Thai and cross-border customers are growing beautifully, and overseas brands are expanding through multiple channels; 3) production capacity in Hubei has been released one after another to establish business expansion, and 4) reduced costs, self-produced raw materials, and increased profitability. (Mainichi Keizai Shimbun)
Haoyue Nursing (605009): 23 years of steady performance, deepening domestic and foreign business layout
Incident: Haoyue Nursing released its 2023 report. In 2023, we achieved operating income of 2,757 billion yuan, a year-on-year decrease of 1.62%, and realized net profit of 439 million yuan, an increase of 3.72% over the previous year, and achieved net income without deduction
Cinda Securities released a research report on April 13 stating that it gave Haoyue Nursing (605009.SH) an increase in its holdings. The main reasons for the rating include: 1) Product revenue was affected by the reduction in raw material prices; own-bran
Cinda Securities released a research report on April 13 stating that it gave Haoyue Nursing (605009.SH) an increase in its holdings. The main reasons for the rating include: 1) Product revenue was affected by the reduction in raw material prices; own-brand wipes grew rapidly, and domestic and foreign production capacity layout continued to deepen; 2) gross margin improved as scheduled, export gross margin performance was impressive, and overall profit was steady. (Mainichi Keizai Shimbun)
Hangzhou Haoyue Personal Care Co., Ltd's (SHSE:605009) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at Hangzhou Haoyue Personal Care's (SHSE:605009) recent performance, when its stock has declined 9.7% over the past week. However, stock prices are usually dr
Hangzhou Haoyue Personal Care Boosts Investment in Subsidiaries
Hangzhou Haoyue Personal Care (SHA:605009) plans to increase its capital investment in two wholly owned subsidiaries to expand their production capacity, according to a Friday filing with the Shanghai
Changes in A-shares | Performance growth declined, and Haoyue Nursing's volume fell by more than 7%
Gelonghui, April 12 | Haoyue Nursing (605009.SH) fell more than 7% to 36 yuan. The turnover increased significantly to 90.25 million yuan, with a market value of 5.6 billion yuan. Yesterday evening, the company released its 2023 annual report: total revenue of 2,757 billion yuan, down 1.62% year on year; net profit of 439 million yuan, up 3.72% year on year. Compared with before listing in 2020, the performance growth rate declined markedly. The sharp increase in sales expenses is an important reason for the limited increase in the company's profit.
Haoyue Nursing (605009): Stable products from the main domestic business go overseas, and the dividend rate is attractive
The 2023 results were slightly lower than our expectations, and Haoyue Nursing announced 2023 results: revenue of 2,757 million yuan, -1.6% year over year; net profit to mother was 439 million yuan, +3.7% year over year. Performance was slightly lower than our expectations
Haoyue Nursing (605009.SH) released 2023 annual results, net profit of 439 million yuan, up 3.72% year on year
Haoyue Nursing (605009.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 2,757 billion yuan, a year-on-year decrease of 1.62%; net profit attributable to shareholders of listed companies was 439 million yuan, an increase of 3.72%; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 423 million yuan, an increase of 7.37% over the previous year; and basic earnings per share were 2.84 yuan/share.
Investors Could Be Concerned With Hangzhou Haoyue Personal Care's (SHSE:605009) Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an e
Analysis
Price Target
No Data
